AUG 07, 2018 8:50 PM PDT

Improving Liver Cancer Therapy

WRITTEN BY: Nouran Amin

According to studies conducted in the United States, the ninth leading causes of cancer deaths is hepatocellular carcinoma, the primary cancer of the liver. Hepatocellular carcinoma tends to grow and expand at an increasingly fast rate and if not diagnosed early on then affected individuals may not always survive longer than 11 months. Specialists seek to treat their patients by usually prescribing a therapeutic drug known as "sorafenib." However, the drug will typically prolong the survival of individuals by only 3 months, and it can bring numerous negative side-effects.

Watch Alternative Treatment Options:

To seek other options in an effort to improve liver cancer treatment, cancer researchers from multiple international institutions have collaborated together to treat a therapeutic drug that holds high efficacy for the treatment of liver cancer. The compound was developed primarily by researchers from the Cancer Institute of Singapore at the National University of Singapore in Queenstown along with colleagues from other global institutions.

The new experimental drug, which researchers refer to as "FFW", holds the potential to treat liver cancer by improving survival rates and lessening adverse effects additionally it is believed to alter the growth of primary liver cancer and help reduce the unwanted effects of typical therapy. In the journal PNAS, the development of FFW is outlined by the researchers in the most recent publication. "In our latest work, [we have] demonstrated an effective strategy to accurately target oncogenes previously considered undruggable," says study co-author and professor at the National University of Singapore, Daniel Tenen.

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 12, 2021
Technology
Belkin Laser Completes Enrollment for Trial Studying New Glaucoma Laser Treatment
MAY 12, 2021
Belkin Laser Completes Enrollment for Trial Studying New Glaucoma Laser Treatment
Belkin Laser, a small Israel-based biotechnology company, has announced that it has completed enrollment for its pivotal ...
JUN 03, 2021
Drug Discovery & Development
Antibiotics Ineffective Against Lung-Scarring Disease
JUN 03, 2021
Antibiotics Ineffective Against Lung-Scarring Disease
Researchers behind a large trial of antibiotics for chronic lung diseases have found that that the drugs are ineffective ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 22, 2021
Neuroscience
Virtual Reality Game Provides Pain Relief for Children
JUN 22, 2021
Virtual Reality Game Provides Pain Relief for Children
Researchers led by Ohio State University have found that smartphone-based virtual reality (VR) games can relieve pain fr ...
JUL 05, 2021
Microbiology
Natural Antibiotic in Chestnut Leaves Can Eliminate MRSA
JUL 05, 2021
Natural Antibiotic in Chestnut Leaves Can Eliminate MRSA
The natural world is full of microbes, fungi, and plants that have given us valuable medicines, like tetracyclines, peni ...
JUL 27, 2021
Drug Discovery & Development
Immune related genes influence antipsychotic-induced weight gain.
JUL 27, 2021
Immune related genes influence antipsychotic-induced weight gain.
Mental disorders such as Schizophrenia and Bipolar disorder are currently incurable, but some symptoms can be treated wi ...
Loading Comments...